Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Front Mol Biosci ; 8: 637124, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34485378

RESUMEN

The expeditious and world pandemic viral disease of new coronavirus (SARS-CoV-2) has formed a prompt urgency to discover auspicious target-based ligand for the treatment of COVID-19. Symptoms of novel coronavirus disease (COVID-19) typically include dry cough, fever, and shortness of breath. Recent studies on many COVID-19 patients in Italy and the United Kingdom found increasing anosmia and ageusia among the COVID-19-infected patients. SARS-CoV-2 possibly infects neurons in the nasal passage and disrupts the senses of smell and taste, like other coronaviruses, such as SARS-CoV and MERS-CoV that could target the central nervous system. Developing a drug based on the T2Rs might be of better understanding and worth finding better molecules to act against COVID-19. In this research, we have taken a taste receptor agonist molecule to find a better core molecule that may act as the best resource to design a drug or corresponding derivatives. Based on the computational docking studies, the antibiotic tobramycin showed the best interaction against 6LU7 COVID-19 main protease. Aromatic carbonyl functional groups of the molecule established intermolecular hydrogen bonding interaction with GLN189 amino acid and it showed the two strongest carbonyl interactions with receptor protein resulting in a glide score of -11.159. To conclude, depending on the molecular recognition of the GPCR proteins, the agonist molecule can be recognized to represent the cell secondary mechanism; thus, it provides enough confidence to design a suitable molecule based on the tobramycin drug.

2.
J Hazard Mater ; 416: 125912, 2021 08 15.
Artículo en Inglés | MEDLINE | ID: mdl-34492846

RESUMEN

Emerging contaminants (ECs) in wastewater have recently attracted the attention of researchers as they pose significant risks to human health and wildlife. This paper presents the state-of-art technologies used to remove ECs from wastewater through a comprehensive review. It also highlights the challenges faced by existing EC removal technologies in wastewater treatment plants and provides future research directions. Many treatment technologies like biological, chemical, and physical approaches have been advanced for removing various ECs. However, currently, no individual technology can effectively remove ECs, whereas hybrid systems have often been found to be more efficient. A hybrid technique of ozonation accompanied by activated carbon was found significantly effective in removing some ECs, particularly pharmaceuticals and pesticides. Despite the lack of extensive research, nanotechnology may be a promising approach as nanomaterial incorporated technologies have shown potential in removing different contaminants from wastewater. Nevertheless, most existing technologies are highly energy and resource-intensive as well as costly to maintain and operate. Besides, most proposed advanced treatment technologies are yet to be evaluated for large-scale practicality. Complemented with techno-economic feasibility studies of the treatment techniques, comprehensive research and development are therefore necessary to achieve a full and effective removal of ECs by wastewater treatment plants.


Asunto(s)
Plaguicidas , Contaminantes Químicos del Agua , Purificación del Agua , Humanos , Eliminación de Residuos Líquidos , Aguas Residuales/análisis , Contaminantes Químicos del Agua/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA